determinants and predictors of study participation can therefore be essential in order to assess validity of population-based studies. In the present investigation, we use register data on sociodemographic conditions and disease history among individuals invited to SCAPIS in order to establish a model that predicts study participation.
Materials and methods
The pilot study of SCAPIS was conducted within the city of Gothenburg, Sweden, in 2012 and designed to add new knowledge about socioeconomic differences in risk factor distributions for cardiopulmonary diseases. The total target population consisted of 24,502 individuals between 50 and 64 years, of which 2243 randomly selected individuals from six residential areas received a written invitation in Swedish to participate in SCAPIS. The areas were selected to represent opposite extremes of socioeconomic status (SES) in the city of Gothenburg. Three of the areas had the highest average income and level of education (high SES) as judged from official statistics and three of the areas had the lowest levels (low SES). Invitations were sent out with the aim of recruiting equal numbers of participants from low and high SES areas. The fractions of invited persons were therefore lower (6-7%) within the three residential areas with high SES than in the three areas with low SES (12-13% invited). The overall participation rate was 50% (1111 participants among 2243 invited individuals). In the high SES areas 559 individuals participated (68%) among 825 invited, whereas 552 individuals participated (39%) in the low SES areas among 1418 invited. Ability to understand instructions and complete questionnaires in Swedish, as judged by the study staff, was an inclusion criterion.
An anonymized data set for the total target population was made available by register authorities (Statistics Sweden and the National Board of Health and Welfare) and included indicators of invitation to and participation in SCAPIS (yes/no) along with register data on residential area, variables reflecting current sociodemographic conditions and disease history. From Statistics Sweden data on country of birth, civil status, education, occupational status, income, sick leave, and retirement for 2011 were obtained from the longitudinal integration database for health insurance and labor market studies (LISA by Swedish acronym). The National Board of Health and Welfare provided data from the National Patient Register on both inpatient and outpatient care during 2000-2011 for the following diagnostic groups: cardiovascular disease (CVD; ICD-10 codes I20-I25, I48, I50, I61-I64) or chest pain (R074), cancer (C00-C97), chronic obstructive lung disease (COPD; J40-J47), diabetes (E10-E14), psychiatric disease (F20-F25, F28-F34, F38-F48, F60-F69), alcohol or substance abuse (F10-F19), pneumonia (J09-J18, only if main diagnosis in inpatient care), abdominal pain (R10). No link between the target population data set and the detailed phenotype data obtained for the SCAPIS participants was available.
We used logistic regression in IBM ® SPSS ® Statistics version 22 in order to establish a model for predicting participation among individuals invited to SCAPIS (n = 2243). Independent variables were categorized, as presented in Table I . Both univariable and multivariable associations with participation were assessed. In the multivariable modelling, we first established a model with all sociodemographic variables included, and then investigated the added classification ability by also including data on disease history. We estimated propensity scores for participation, i.e. the probability of receiving some program or treatment (here participation in SCAPIS) [4, 5] , for all invited individuals based on the multivariable models. The area under the receiver operating characteristic (ROC) curve was used as a measure of the overall ability of the models to predict participation.
results
All sociodemographic variables except sex were associated with participation (p < 0.05) in univariable models. Participants and non-participants also exhibited clear differences with respect to disease history overall, although it is worth noting that, for example, history of CVD did not differ markedly (Table I ).
The multivariable model with all sociodemographic variables included resulted in fair classification ability (area under the ROC curve = 72.7%). Adding data on disease history only increased overall classification ability marginally (area under the ROC curve = 73.2%). The associations with previous diagnoses were diverse with ORs for participation ranging between 0.4 (pneumonia) and 1.3 (abdominal pain) in the final model and generally with wide confidence intervals (Table I) . Any prior diagnosis of CVD, cancer or COPD was associated with increased participation (odds ratio 1.2, 95% confidence interval 1.0-1.5, p = 0.04; not in table). Besides residential area (high/low SES), country of birth, civil status, education, occupational status, and disposable income were still clearly associated with participation in the final model. The distribution of these five sociodemographic variables differed markedly across areas, but exhibited similar associations with participation both in areas with low SES and high SES (results not shown).
Discussion
The present study illustrates the broad usefulness of register data of the kind available in the Nordic countries. Available register data on sociodemographic conditions and disease history revealed striking differences in participation rates across different population groups. There was a fivefold relative difference in participation between the deciles with lowest and highest propensity to participate in SCAPIS (19% vs. 76%). A particularly low participation rate (11%; model-based estimate) was found among individuals born outside Europe, living single in a low SES area, having low education, being outside the labor market and having low income.
The presented results have, together with similar investigations [3] , important implications for general population studies. One important implication is that considerable selection effects, i.e. differences between participants and non-participants, remain despite the increased sampling fractions in areas with low SES. Sample stratification on or statistical adjustment for residential area will therefore not be sufficient to enhance validity; access to detailed register data is required. Another implication is that most of the differences in disease history between participants and non-participants were attributable to differences in sociodemographic conditions. Access to data on sociodemography for non-participants can therefore be expected to be more important in order to assess validity than data on health and disease. The estimated associations between disease history and participation were generally statistically imprecise, but nevertheless suggest that some disease groups are negatively associated with participation (e.g. pneumonia and alcohol or substance abuse) whereas some others (CVD, cancer, and COPD) tend to increase participation. Since most diseases were associated with sociodemographic conditions, it can be deceptive to judge validity by comparing disease history in isolation. As an example, the proportion of individuals with a prior history of CVD, cancer or COPD among individuals invited to the SCAPIS pilot study was similar among participants and non-participants (24% in both groups). A plausible explanation for these seemingly comparable disease risks could be a complex selection process where low participation from socioeconomic conditions associated with increased risks of these diseases is balanced by an increased willingness to participate among persons with these diseases. Results from present investigation suggest that participation in population-based studies can be expected to be related to both sociodemographic conditions and health status at baseline. Figure 1 depicts a causal diagram for a hypothetical cohort study investigating the strength of an exposureoutcome association with the exposure measured at baseline (t = 0) and the health outcome assessed during follow-up (t > 0). The investigation will be conditioned on study participation, i.e. only individuals that participated at baseline will be followed longitudinally. Conditioning on study participation is the origin of sample selection bias [6] , i.e. bias in the estimated exposure effect would arise if there are common causes (common determinants) of study participation and the health outcome that are not adjusted for. Adjustments may become intractable using standard multivariable regression, especially in studies of rare diseases (with few cases) if the list of determinants is long. An appealing alternative is to use inverse probability treatment weights based on propensity scores to correct for selection bias (cf. Stuart et al. [5] ). For the SCAPIS study, this would require that register data are linked also to the detailed phenotype data obtained for the SCAPIS participants such that the propensity scores could be calculated based on the established multivariable models in the present investigation.
Selective participation is also a threat to external validity. The overall effect of each risk factor in an exposure-disease prediction model is an average effect that has been weighted by the distributions of individuals across subgroups in the study cohort. Varying effects across subgroups can appear due to undisclosed reasons, e.g. underlying interaction effects between risk factors, exposure or confounder misclassification within certain subgroups. Such heterogeneity in effects implies that a risk prediction model established on SCAPIS participants may not have the same predictive ability in the target population with a different distribution of risk factors. The main focus of the SCAPIS project is to better understand how new risk factor patterns in the population affects cardiovascular and pulmonary disease development. In that respect, internal validity (including absence of selection bias) is more important than representativeness [7] . However, a secondary goal is to describe how new risk patterns has evolved in society and to use this information to influence policy discussions on public-health issues. For this purpose, improved statistical methodology to achieve a better generalizability of results is of great importance, especially as participation rates in population-based studies are on decline [8] . As participation is tightly linked to sociodemographic conditions, the propensity scores can be a useful tool for illustrating heterogeneity of exposure effects across population groups [9] , and can also be used in the statistical analyses to assess and enhance generalizability [5] .
In conclusion, the present investigation stresses the importance of a careful consideration of selection effects in population-based studies. Access to detailed register data also for non-participants can in the statistical analysis be used to control for selection bias and enhance generalizability, thereby making the results more relevant for policy decisions. Figure 1 . Selection bias related to study participation in a hypothetical cohort study investigating the strength of the effect of an exposure at baseline (t = 0) on a health outcome during follow-up (t > 0). Failure to adjust for common determinants of study participation and the health outcome would bias the exposure effect (dashed arrow).
